Case Report: amplification in two adult patients with B-cell acute lymphoblastic leukemia.
증례보고
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
추출되지 않음
I · Intervention 중재 / 시술
induction chemotherapy but passed away after two months due to complications
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
Our review underscores the need for genetic profiling to improve risk stratification and treatment. Given the limited documented cases, further research is essential to develop better therapeutic strategies for -amplified B-ALL.
The gene, located at chromosome band 11q23, encodes a lysine methyltransferase essential for hematopoietic gene regulation.
APA
Gao M, Chen Y, et al. (2026). Case Report: amplification in two adult patients with B-cell acute lymphoblastic leukemia.. Frontiers in oncology, 16, 1656404. https://doi.org/10.3389/fonc.2026.1656404
MLA
Gao M, et al.. "Case Report: amplification in two adult patients with B-cell acute lymphoblastic leukemia.." Frontiers in oncology, vol. 16, 2026, pp. 1656404.
PMID
41836231 ↗
Abstract 한글 요약
The gene, located at chromosome band 11q23, encodes a lysine methyltransferase essential for hematopoietic gene regulation. While rearrangements are common in acute myeloid leukemia (AML) and B-cell acute lymphoblastic leukemia (B-ALL), amplification is rare, occurring in ~1% of AML cases and even less frequently in B-ALL. Given its rarity, understanding amplification in B-ALL is crucial for improving diagnostics and therapy. We report two adult B-ALL cases with amplification. Patient 1, a 58-year-old male, had amplification (6~18 copies in 68.5% of bone marrow cells), a complex karyotype, and a pathogenic variant (c.524G>A, p.Arg175His). He underwent induction chemotherapy but passed away after two months due to complications. Patient 2, a 66-year-old female, had amplification (8~11 copies in 87.5% of peripheral blood cells) and rearrangement, representing the first reported case of Ph-like B-ALL with amplification in an adult. She deteriorated rapidly and died within four days. In addition to these two cases from our cohort, we review nine published cases with amplification in B-ALL, which showed frequent alterations, emphasizing the clinical and genetic characteristics of this aggressive leukemia subtype. These cases highlight the high-risk nature of -amplified B-ALL, particularly in older adults, where prognosis is poor and linked to variants or rearrangement. Our review underscores the need for genetic profiling to improve risk stratification and treatment. Given the limited documented cases, further research is essential to develop better therapeutic strategies for -amplified B-ALL.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- Integrating single-cell and spatial transcriptomics to dissect mast-cell heterogeneity and arginine-metabolism-associated markers in BRCA.
- Engineering Hafnium Oxide-Based Nanoplatforms for Precision Radiosensitization.
- Disruption of Signalling Pathways Induced by HBV HBx, HCV Core, and EBV LMP1 in Gastric Cancer.
- Characteristics and Antibacterial Activity of Staphylococcus aureus Phage-Derived Endolysin LysP4.
- Shaping Tumor Microenvironment by Amplifying the Complement Cascade for Improved Immune Response in Pancreatic Cancer Model.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Eruptive juvenile xanthogranuloma and B-cell acute lymphoblastic leukemia in a child: Case report and literature review.
- Long non-coding RNAs in B-cell acute lymphoblastic leukemia: Disease implication, challenges and therapeutic opportunities.
- Measurable Residual Disease Assessment in B-Lymphoblastic Leukemia Using 5- and 10-Color Flow Cytometry: An Institutional Experience.
- Evaluation of the diagnostic and prognostic role of TSPAN32 in B-cell acute lymphoblastic leukemia.
- A case report and a literature review of Myeloid/Lymphoid Neoplasm with Eosinophilia and PCM1::JAK2 rearrangement representing as B-cell acute lymphoblastic leukemia B-ALL.
- Editorial: Mechanisms and therapeutic opportunities of T-cell impairment in cancer immunity and immunotherapy.